Type 1 and Type 2 Respiratory Failure Based on ABG
Type 1 respiratory failure is defined by PaO₂ <8 kPa (60 mmHg) with normal or low PaCO₂, while Type 2 respiratory failure is defined by PaO₂ <8 kPa AND PaCO₂ >6.0 kPa (45 mmHg). 1
ABG Criteria for Classification
Type 1 (Hypoxemic) Respiratory Failure
- PaO₂ <8 kPa (60 mmHg) - equivalent to SpO₂ approximately 90% 1
- PaCO₂ normal (4.6-6.1 kPa) or low 1
- Results from failure of oxygenation despite adequate ventilation 1
Type 2 (Hypercapnic) Respiratory Failure
- PaO₂ <8 kPa (60 mmHg) 1
- PaCO₂ >6.0 kPa (45 mmHg) - this is the critical distinguishing feature 1
- Often accompanied by respiratory acidosis (pH <7.35) when acute 1
Important threshold clarification: The BTS/ICS guidelines specify that NIV should be considered when PaCO₂ is between 6.0-6.5 kPa, but NIV should be started when PaCO₂ ≥6.5 kPa with pH <7.35 after optimal medical therapy. 1
Key Distinguishing Features on ABG
Acute vs. Chronic Type 2 Failure
- Acute hypercapnic respiratory failure: pH <7.35 with elevated PaCO₂, indicating insufficient renal compensation 1
- Chronic compensated: Normal or near-normal pH despite elevated PaCO₂, due to renal bicarbonate retention over hours to days 1
- Acute-on-chronic: Elevated PaCO₂ with pH <7.35 despite baseline bicarbonate elevation 1
Critical pH Thresholds
- pH <7.35 (H⁺ >45 nmol/L) defines respiratory acidosis and triggers consideration for NIV 1
- pH <7.25 indicates severe acidosis with higher mortality risk 2
- Arterial hydrogen ion concentration is a more important prognostic factor than the degree of hypoxemia or hypercapnia alone 2
Common Pitfalls in ABG Interpretation
Oxygen Therapy Confounding
- Measuring PaO₂ after oxygen administration can mask the diagnosis of respiratory failure - use PaO₂/FiO₂ ratio instead when patients are already on supplemental oxygen 3
- In one study, using PaO₂/FiO₂ ratio identified an additional 16 cases of respiratory failure that would have been missed using PaO₂ alone 3
Mixed Type 1 and Type 2 Failure
- Both types can coexist - using PaCO₂ alone to classify can be misleading 3
- Calculate the alveolar-arterial (A-a) gradient to determine if hypercapnia is due to hypoventilation (Type 2) or V/Q mismatch (Type 1 with secondary hypercapnia) 3
- In one study, 22 of 57 cases initially classified as Type 2 using PaCO₂ alone were reclassified as Type 1 when A-a gradient was calculated, changing management in 18 cases 3
Practical ABG Interpretation Algorithm
First, assess oxygenation:
Second, assess ventilation:
Third, assess acuity:
Fourth, calculate A-a gradient if both hypoxemia and hypercapnia present:
Management Implications Based on ABG
Type 1 Failure
- Target SpO₂ 94-98% in most patients 1
- High-flow nasal oxygen may reduce intubation rates 4
- Does not typically respond to NIV unless specific indications present 4
Type 2 Failure
- Target SpO₂ 88-92% to avoid worsening hypercapnia 1, 4
- Repeat ABG after 1 hour of optimal medical therapy to determine if NIV is needed 1
- Start NIV when pH <7.35 and PaCO₂ ≥6.5 kPa persist after initial treatment 1
- Repeat ABG 1-2 hours after starting NIV, then again at 4-6 hours to assess response 1, 4
Critical Warning
Never administer high-flow oxygen to patients with suspected Type 2 failure without ABG confirmation and close monitoring - this can precipitate CO₂ narcosis and respiratory arrest. 4